REVEFENACIN

REVEFENACIN was reported 921 times

REVEFENACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRACHEAL POLYP 1 0.3333
1 ARGON PLASMA COAGULATION 1 0.1250
2 MYOCARDIAL NECROSIS MARKER DECREASED 1 0.1111
3 PERIPHERAL ARTERY RESTENOSIS 1 0.1000
4 ATHERECTOMY 1 0.0556
5 VERTEBRAL ARTERY ANEURYSM 1 0.0500
6 CONGENITAL NEUROPATHY 1 0.0400
7 OESOPHAGEAL MUCOSAL BLISTER 1 0.0345
8 LOW LUNG COMPLIANCE 1 0.0256
9 ORBITAL SWELLING 1 0.0172
10 AVIAN INFLUENZA 1 0.0156
11 URETHRAL CARUNCLE 1 0.0149
12 COUGH VARIANT ASTHMA 1 0.0119
13 DILATED PORES 1 0.0110
14 PERIPORTAL OEDEMA 1 0.0080
15 MONONEURITIS 1 0.0064
16 LUNG DIFFUSION DISORDER 1 0.0064
17 INFLUENZA B VIRUS TEST POSITIVE 1 0.0055
18 INFLUENZA VIRUS TEST POSITIVE 1 0.0047
19 BENDOPNOEA 1 0.0045
20 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
21 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
22 CORONARY ARTERY ANEURYSM 1 0.0043
23 CREST SYNDROME 1 0.0042
24 DIABETIC VASCULAR DISORDER 1 0.0040
25 PROLONGED EXPIRATION 1 0.0038
26 DILATATION INTRAHEPATIC DUCT ACQUIRED 1 0.0034
27 TONGUE HAEMORRHAGE 4 0.0034
28 VOCAL CORD INFLAMMATION 1 0.0034
29 BRONCHOSPASM PARADOXICAL 1 0.0033
30 CARBON DIOXIDE ABNORMAL 1 0.0032
31 VASCULAR COMPRESSION 1 0.0032
32 CELLULITE 1 0.0031
33 WRONG STRENGTH 1 0.0030
34 GASTRIC MUCOSA ERYTHEMA 1 0.0030
35 CATHETER SITE BRUISE 1 0.0030
36 IODINE ALLERGY 1 0.0030
37 ADMINISTRATION SITE BRUISE 1 0.0029
38 CHRONIC RESPIRATORY DISEASE 1 0.0028
39 PRODUCT DOSE CONFUSION 1 0.0028
40 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
41 LOWER URINARY TRACT SYMPTOMS 1 0.0028
42 SINONASAL OBSTRUCTION 1 0.0025
43 GRANULOCYTE COUNT INCREASED 1 0.0025
44 OROPHARYNGEAL SPASM 1 0.0024
45 LUNG HYPERINFLATION 2 0.0023
46 DEGENERATIVE BONE DISEASE 1 0.0023
47 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
48 PNEUMONIA PSEUDOMONAL 3 0.0020
49 TRACHEAL DISORDER 1 0.0019
50 RESPIRATORY TRACT IRRITATION 2 0.0019
51 INADEQUATE DIET 1 0.0019
52 CORYNEBACTERIUM INFECTION 1 0.0019
53 INTERTRIGO 1 0.0018
54 GENITAL DISCOMFORT 1 0.0018
55 HYPERTENSIVE URGENCY 1 0.0018
56 ROTAVIRUS INFECTION 1 0.0017
57 CYANOPSIA 1 0.0017
58 CHRONIC RESPIRATORY FAILURE 2 0.0017
59 INFUSION SITE WARMTH 2 0.0016
60 MITRAL VALVE CALCIFICATION 1 0.0016
61 BLOOD PRESSURE MEASUREMENT 1 0.0016
62 STAPHYLOCOCCAL ABSCESS 1 0.0016
63 CHONDROCALCINOSIS 1 0.0015
64 SCLERAL DISCOLOURATION 1 0.0015
65 LUNG TRANSPLANT REJECTION 1 0.0015
66 PNEUMOTHORAX SPONTANEOUS 1 0.0015
67 CALCULUS BLADDER 2 0.0015
68 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
69 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
70 LIMB CRUSHING INJURY 1 0.0013
71 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
72 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
73 GASTROINTESTINAL SURGERY 1 0.0013
74 HEAT EXHAUSTION 1 0.0012
75 DYSCHROMATOPSIA 1 0.0012
76 LUNG OPERATION 1 0.0012
77 MEAN PLATELET VOLUME DECREASED 1 0.0012
78 NODAL ARRHYTHMIA 1 0.0012
79 RESPIRATION ABNORMAL 8 0.0012
80 TONGUE COATED 2 0.0012
81 OESOPHAGEAL OBSTRUCTION 1 0.0012
82 INFUSION SITE DISCHARGE 2 0.0011
83 INFUSION SITE DISCOLOURATION 1 0.0011
84 ARTERIOVENOUS MALFORMATION 1 0.0011
85 PNEUMONIA CRYPTOCOCCAL 1 0.0011
86 PRODUCT AFTER TASTE 1 0.0010
87 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I 1 0.0010
88 INFUSION SITE DISCOMFORT 1 0.0010
89 SINUSITIS BACTERIAL 1 0.0009
90 BONE DEMINERALISATION 1 0.0009
91 INFUSION SITE BRUISING 2 0.0009
92 INFUSION SITE MASS 1 0.0009
93 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
94 MIDDLE EAR EFFUSION 2 0.0009
95 STRESS AT WORK 1 0.0009
96 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
97 PRURITUS ALLERGIC 1 0.0009
98 INCISION SITE PAIN 1 0.0009
99 OXYGEN CONSUMPTION INCREASED 2 0.0008
100 POST-ACUTE COVID-19 SYNDROME 1 0.0008
101 SUFFOCATION FEELING 2 0.0008
102 NASAL PRURITUS 1 0.0008
103 VASODILATATION 2 0.0008
104 HYPERAESTHESIA TEETH 1 0.0008
105 INCREASED BRONCHIAL SECRETION 2 0.0008
106 INFUSION SITE IRRITATION 1 0.0008
107 AORTIC ARTERIOSCLEROSIS 2 0.0008
108 REHABILITATION THERAPY 3 0.0008
109 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
110 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
111 CARBON DIOXIDE INCREASED 1 0.0007
112 INFUSION SITE RASH 1 0.0007
113 IMMUNOGLOBULINS DECREASED 1 0.0007
114 DISCHARGE 1 0.0007
115 INFUSION SITE ERYTHEMA 6 0.0007
116 BLOOD ELECTROLYTES DECREASED 1 0.0007
117 POST HERPETIC NEURALGIA 1 0.0007
118 DYSPNOEA AT REST 2 0.0007
119 URINARY RETENTION 23 0.0007
120 STRIDOR 2 0.0007
121 ANGIOPLASTY 1 0.0007
122 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
123 MULTIPLE ALLERGIES 5 0.0006
124 SEASONAL ALLERGY 9 0.0006
125 INFUSION SITE SWELLING 4 0.0006
126 INTERMITTENT CLAUDICATION 1 0.0006
127 BRONCHOSPASM 9 0.0006
128 ANTICHOLINERGIC SYNDROME 1 0.0006
129 TOTAL LUNG CAPACITY DECREASED 1 0.0006
130 PHARYNGEAL SWELLING 6 0.0006
131 SHOULDER FRACTURE 1 0.0006
132 OXYGEN THERAPY 1 0.0006
133 BREATH SOUNDS ABNORMAL 3 0.0006
134 BLOOD CALCIUM ABNORMAL 1 0.0006
135 VEIN RUPTURE 1 0.0006
136 EMPHYSEMA 6 0.0006
137 EXPOSURE TO SARS-COV-2 1 0.0006
138 INJECTION SITE OEDEMA 1 0.0006
139 LOGORRHOEA 2 0.0006
140 KYPHOSIS 1 0.0006
141 TERMINAL INSOMNIA 1 0.0006
142 AORTIC VALVE STENOSIS 1 0.0006
143 NASAL OEDEMA 1 0.0006
144 ESSENTIAL HYPERTENSION 1 0.0005
145 SINUS NODE DYSFUNCTION 1 0.0005
146 METAMORPHOPSIA 1 0.0005
147 CYSTIC FIBROSIS 3 0.0005
148 RESPIRATORY TRACT INFECTION 14 0.0005
149 OXYGEN SATURATION DECREASED 30 0.0005
150 NASAL OBSTRUCTION 1 0.0005
151 LIP DISORDER 1 0.0005
152 GASTRIC INFECTION 2 0.0005
153 ADRENAL DISORDER 1 0.0005
154 MOUTH SWELLING 3 0.0005
155 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
156 RESPIRATORY ACIDOSIS 2 0.0005
157 HOSPICE CARE 5 0.0005
158 EYELID PAIN 1 0.0005
159 CHANGE OF BOWEL HABIT 1 0.0005
160 RENAL MASS 1 0.0005
161 BODY TEMPERATURE FLUCTUATION 1 0.0005
162 DEVICE CONNECTION ISSUE 1 0.0005
163 SPUTUM INCREASED 1 0.0005
164 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
165 LIMB MASS 1 0.0005
166 NOSOCOMIAL INFECTION 1 0.0005
167 CLOSTRIDIUM TEST POSITIVE 1 0.0005
168 DISTRIBUTIVE SHOCK 1 0.0004
169 VASCULAR DEVICE INFECTION 2 0.0004
170 INFUSION SITE INFECTION 1 0.0004
171 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
172 DYSPNOEA 240 0.0004
173 SINUS OPERATION 1 0.0004
174 ACUTE RESPIRATORY FAILURE 8 0.0004
175 HAEMATOLOGICAL INFECTION 1 0.0004
176 PSYCHIATRIC SYMPTOM 3 0.0004
177 HYPERVOLAEMIA 2 0.0004
178 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
179 DEVICE INFUSION ISSUE 1 0.0004
180 CANCER PAIN 1 0.0004
181 INFUSION SITE PAIN 5 0.0004
182 HERNIA REPAIR 1 0.0004
183 RESPIRATORY TRACT CONGESTION 6 0.0004
184 PRODUCTIVE COUGH 18 0.0004
185 GINGIVAL PAIN 3 0.0004
186 PROTEIN TOTAL INCREASED 1 0.0004
187 DYSPNOEA EXERTIONAL 14 0.0004
188 WHEEZING 22 0.0004
189 SKIN LACERATION 4 0.0004
190 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
191 LIP BLISTER 1 0.0004
192 RHINALGIA 1 0.0004
193 HYPERKERATOSIS 2 0.0004
194 PROSTATIC DISORDER 2 0.0004
195 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
196 ORAL PAIN 8 0.0004
197 OXYGEN SATURATION ABNORMAL 1 0.0004
198 FACIAL PARALYSIS 3 0.0004
199 RESPIRATORY SYMPTOM 1 0.0004
200 PSEUDOMONAS INFECTION 3 0.0003
201 LIP PAIN 1 0.0003
202 HYPERVENTILATION 2 0.0003
203 BILIARY COLIC 1 0.0003
204 DEVICE POWER SOURCE ISSUE 1 0.0003
205 PULMONARY PAIN 1 0.0003
206 ATYPICAL PNEUMONIA 1 0.0003
207 METABOLIC ENCEPHALOPATHY 1 0.0003
208 THROAT TIGHTNESS 9 0.0003
209 OROPHARYNGEAL DISCOMFORT 3 0.0003
210 HYPERCAPNIA 1 0.0003
211 BONE MARROW DISORDER 1 0.0003
212 EMBOLISM VENOUS 1 0.0003
213 INGUINAL HERNIA 2 0.0003
214 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
215 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
216 INFUSION SITE EXTRAVASATION 2 0.0003
217 THERAPY PARTIAL RESPONDER 5 0.0003
218 BLEPHAROSPASM 2 0.0003
219 INFUSION SITE PRURITUS 1 0.0003
220 SPUTUM DISCOLOURED 3 0.0003
221 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
222 PNEUMONIA VIRAL 1 0.0003
223 CHEST DISCOMFORT 32 0.0003
224 LOOSE TOOTH 1 0.0003
225 PORTAL VEIN THROMBOSIS 1 0.0003
226 VITREOUS FLOATERS 3 0.0003
227 INFUSION SITE HAEMORRHAGE 1 0.0003
228 NEAR DEATH EXPERIENCE 1 0.0003
229 PERICARDIAL EFFUSION 7 0.0003
230 PEPTIC ULCER 1 0.0003
231 RESPIRATORY DISORDER 9 0.0003
232 BRONCHIECTASIS 2 0.0003
233 CANDIDA INFECTION 5 0.0003
234 TONGUE ULCERATION 1 0.0003
235 POOR VENOUS ACCESS 3 0.0003
236 LYMPHOEDEMA 2 0.0003
237 DEPRESSION SUICIDAL 1 0.0003
238 HYPOPNOEA 1 0.0003
239 ORAL DISCOMFORT 4 0.0003
240 CAROTID ARTERY STENOSIS 1 0.0003
241 EAR PRURITUS 1 0.0003
242 BRONCHIOLITIS 1 0.0003
243 PAPULE 2 0.0003
244 LUNG TRANSPLANT 1 0.0003
245 DECREASED ACTIVITY 3 0.0003
246 APPARENT DEATH 1 0.0003
247 TONGUE DISORDER 2 0.0003
248 SCLERODERMA 1 0.0003
249 ORAL DISORDER 2 0.0003
250 ARTHROPOD BITE 2 0.0003
251 RETINOPATHY 1 0.0003
252 PRODUCT STORAGE ISSUE 1 0.0003
253 PARANASAL SINUS HYPERSECRETION 1 0.0003
254 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
255 INSURANCE ISSUE 4 0.0003
256 PULMONARY FIBROSIS 5 0.0003
257 THYROID MASS 1 0.0003
258 GINGIVAL DISORDER 1 0.0003
259 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
260 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
261 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
262 RHINOVIRUS INFECTION 1 0.0003
263 EPIGASTRIC DISCOMFORT 1 0.0003
264 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
265 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
266 HYPERPHAGIA 1 0.0003
267 INTRACRANIAL ANEURYSM 1 0.0002
268 VITAMIN B12 DEFICIENCY 1 0.0002
269 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
270 COUGH 68 0.0002
271 PHARYNGITIS 3 0.0002
272 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
273 INJECTION SITE DISCOLOURATION 3 0.0002
274 SECRETION DISCHARGE 3 0.0002
275 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
276 TONGUE DISCOMFORT 1 0.0002
277 POOR PERIPHERAL CIRCULATION 1 0.0002
278 CARDIAC FAILURE CHRONIC 1 0.0002
279 HEPATIC PAIN 1 0.0002
280 INTERVERTEBRAL DISC DISORDER 1 0.0002
281 PULMONARY TUBERCULOSIS 1 0.0002
282 HIATUS HERNIA 3 0.0002
283 HORDEOLUM 1 0.0002
284 CHAPPED LIPS 1 0.0002
285 PULMONARY FUNCTION TEST DECREASED 1 0.0002
286 GROIN PAIN 2 0.0002
287 SPINAL OSTEOARTHRITIS 2 0.0002
288 PULMONARY CONGESTION 3 0.0002
289 WHEELCHAIR USER 1 0.0002
290 RHINITIS ALLERGIC 1 0.0002
291 LUNG DISORDER 11 0.0002
292 BRAIN NEOPLASM MALIGNANT 1 0.0002
293 GASTROINTESTINAL INFECTION 2 0.0002
294 HEART RATE INCREASED 22 0.0002
295 URINARY TRACT DISORDER 1 0.0002
296 TACHYPNOEA 3 0.0002
297 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
298 IMMUNE THROMBOCYTOPENIA 1 0.0002
299 PNEUMONIA BACTERIAL 2 0.0002
300 IRON DEFICIENCY ANAEMIA 2 0.0002
301 LOCALISED OEDEMA 1 0.0002
302 RENAL FUNCTION TEST ABNORMAL 1 0.0002
303 APHONIA 3 0.0002
304 FLANK PAIN 2 0.0002
305 SKIN TIGHTNESS 1 0.0002
306 SQUAMOUS CELL CARCINOMA 2 0.0002
307 SKIN ABRASION 1 0.0002
308 HYPERCHOLESTEROLAEMIA 2 0.0002
309 PRESCRIBED OVERDOSE 4 0.0002
310 DIZZINESS POSTURAL 2 0.0002
311 ASTHMA 23 0.0002
312 SINUS DISORDER 4 0.0002
313 BLADDER DISORDER 2 0.0002
314 RHINORRHOEA 13 0.0002
315 HYPERNATRAEMIA 1 0.0002
316 THROAT IRRITATION 9 0.0002
317 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
318 PATHOLOGICAL FRACTURE 1 0.0002
319 AMMONIA INCREASED 1 0.0002
320 EUPHORIC MOOD 2 0.0002
321 MUSCULOSKELETAL CHEST PAIN 3 0.0002
322 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
323 EXPOSURE VIA SKIN CONTACT 5 0.0002
324 CYANOSIS 3 0.0002
325 SENSITIVITY TO WEATHER CHANGE 1 0.0002
326 COMPRESSION FRACTURE 1 0.0002
327 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
328 SINUSITIS 19 0.0002
329 CHEILITIS 1 0.0002
330 OROPHARYNGEAL PAIN 17 0.0002
331 ASPIRATION 2 0.0002
332 ASTHENOPIA 1 0.0002
333 CHOKING SENSATION 1 0.0002
334 LIP SWELLING 6 0.0002
335 HAEMOPTYSIS 5 0.0002
336 WOUND 5 0.0002
337 PULMONARY OEDEMA 8 0.0002
338 SNEEZING 4 0.0002
339 SKIN INFECTION 2 0.0002
340 PERIORBITAL SWELLING 1 0.0002
341 PAIN IN JAW 5 0.0002
342 BRONCHITIS 13 0.0002
343 DERMATITIS CONTACT 2 0.0002
344 PERIPHERAL SWELLING 27 0.0002
345 CARDIAC VALVE DISEASE 1 0.0002
346 EXERCISE TOLERANCE DECREASED 1 0.0002
347 BLOOD URIC ACID INCREASED 1 0.0002
348 DRY MOUTH 14 0.0002
349 HYPERTRIGLYCERIDAEMIA 1 0.0002
350 HYPOXIA 6 0.0002
351 CATARACT OPERATION 1 0.0002
352 PLEURISY 1 0.0002
353 THERAPY INTERRUPTED 12 0.0002
354 MACULAR DEGENERATION 2 0.0002
355 BLOOD POTASSIUM DECREASED 5 0.0002
356 LOCALISED INFECTION 4 0.0002
357 SCOLIOSIS 1 0.0002
358 DYSARTHRIA 6 0.0002
359 GLAUCOMA 3 0.0002
360 HAEMOGLOBIN ABNORMAL 1 0.0002
361 HERNIA 3 0.0002
362 CARDIAC FLUTTER 1 0.0002
363 CHOKING 3 0.0002
364 TENDON DISORDER 1 0.0002
365 VISION BLURRED 21 0.0002
366 ASPERGILLUS INFECTION 1 0.0002
367 HYPOGAMMAGLOBULINAEMIA 1 0.0002
368 BEDRIDDEN 2 0.0002
369 ORAL CANDIDIASIS 2 0.0002
370 TOOTH INFECTION 2 0.0002
371 PNEUMONIA 49 0.0002
372 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
373 UPPER LIMB FRACTURE 3 0.0002
374 CARDIAC FAILURE ACUTE 1 0.0001
375 FULL BLOOD COUNT DECREASED 3 0.0001
376 SINUS CONGESTION 2 0.0001
377 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
378 PRODUCT LABEL ISSUE 1 0.0001
379 IMPAIRED GASTRIC EMPTYING 2 0.0001
380 GINGIVAL BLEEDING 2 0.0001
381 CORONARY ARTERY OCCLUSION 2 0.0001
382 CHEST PAIN 27 0.0001
383 ILLNESS 15 0.0001
384 DROOLING 1 0.0001
385 PULMONARY HYPERTENSION 3 0.0001
386 HYPERTRANSAMINASAEMIA 1 0.0001
387 ATRIAL FIBRILLATION 14 0.0001
388 EYE PAIN 8 0.0001
389 DUODENAL ULCER 1 0.0001
390 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
391 THERMAL BURN 1 0.0001
392 EATING DISORDER 3 0.0001
393 RETCHING 3 0.0001
394 URINARY TRACT INFECTION 24 0.0001
395 PRODUCT SUPPLY ISSUE 1 0.0001
396 HYPERSOMNIA 4 0.0001
397 SKIN CANCER 3 0.0001
398 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
399 RESPIRATORY FAILURE 10 0.0001
400 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
401 DYSSTASIA 4 0.0001
402 DYSPHONIA 8 0.0001
403 MOUTH HAEMORRHAGE 1 0.0001
404 DYSURIA 5 0.0001
405 CARDIOMYOPATHY 2 0.0001
406 CEREBRAL DISORDER 1 0.0001
407 TACHYCARDIA 12 0.0001
408 EYE SWELLING 5 0.0001
409 CATARACT 8 0.0001
410 PULMONARY MASS 2 0.0001
411 HYPOAESTHESIA ORAL 2 0.0001
412 PEMPHIGOID 1 0.0001
413 THERAPEUTIC RESPONSE DECREASED 8 0.0001
414 AORTIC ANEURYSM 1 0.0001
415 COVID-19 23 0.0001
416 BOWEL MOVEMENT IRREGULARITY 1 0.0001
417 DEVICE RELATED INFECTION 2 0.0001
418 FOOD ALLERGY 1 0.0001
419 ATRIOVENTRICULAR BLOCK 1 0.0001
420 PRODUCT DOSE OMISSION ISSUE 38 0.0001
421 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
422 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
423 BASAL CELL CARCINOMA 2 0.0001
424 GASTROINTESTINAL INFLAMMATION 1 0.0001
425 BRAIN FOG 2 0.0001
426 NASAL DISCOMFORT 1 0.0001
427 PNEUMOTHORAX 2 0.0001
428 PRODUCT PRESCRIBING ERROR 3 0.0001
429 ULCER 2 0.0001
430 INFLUENZA 14 0.0001
431 OBESITY 2 0.0001
432 SCIATICA 2 0.0001
433 CONTUSION 12 0.0001
434 BLISTER 7 0.0001
435 STENT PLACEMENT 1 0.0001
436 MYASTHENIA GRAVIS 1 0.0001
437 FRUSTRATION TOLERANCE DECREASED 1 0.0001
438 HYPOGLYCAEMIA 6 0.0001
439 POST PROCEDURAL INFECTION 1 0.0001
440 SWELLING FACE 8 0.0001
441 SUBSTANCE ABUSE 1 0.0001
442 DECUBITUS ULCER 1 0.0001
443 ABNORMAL FAECES 1 0.0001
444 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
445 SPINAL COMPRESSION FRACTURE 1 0.0001
446 EOSINOPHIL COUNT INCREASED 1 0.0001
447 POLLAKIURIA 5 0.0001
448 EYE PRURITUS 4 0.0001
449 HOSPITALISATION 18 0.0001
450 SCAR 2 0.0001
451 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
452 MUSCULOSKELETAL DISCOMFORT 2 0.0001
453 PARANOIA 2 0.0001
454 MUSCLE STRAIN 1 0.0001
455 SKIN SWELLING 1 0.0001
456 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
457 PRODUCT COMMUNICATION ISSUE 1 0.0001
458 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
459 VISUAL IMPAIRMENT 14 0.0001
460 HEAD DISCOMFORT 2 0.0001
461 EAR INFECTION 3 0.0001
462 RESPIRATORY RATE INCREASED 1 0.0001
463 CARDIAC FAILURE CONGESTIVE 9 0.0001
464 THIRST 2 0.0001
465 BACK PAIN 26 0.0001
466 HAEMOLYTIC ANAEMIA 1 0.0001
467 ANAL INCONTINENCE 1 0.0001
468 LEUKOCYTOSIS 2 0.0001
469 RESTLESS LEGS SYNDROME 2 0.0001
470 PANIC ATTACK 4 0.0001
471 NEPHROLITHIASIS 5 0.0001
472 BRAIN NEOPLASM 1 0.0001
473 RESPIRATORY DISTRESS 3 0.0001
474 UROSEPSIS 1 0.0001
475 PRODUCT DISTRIBUTION ISSUE 1 0.0001
476 CONJUNCTIVITIS 2 0.0001
477 DEMENTIA 3 0.0001
478 THINKING ABNORMAL 2 0.0001
479 BACTERIAL INFECTION 2 0.0001
480 MIDDLE INSOMNIA 2 0.0001
481 APPENDICITIS 1 0.0001
482 CARDIAC DISORDER 10 0.0001
483 PHOTOPHOBIA 2 0.0001
484 ARTERIOSCLEROSIS 1 0.0001
485 BLOOD SODIUM DECREASED 2 0.0001
486 OCULAR HYPERAEMIA 5 0.0001
487 BLOOD URINE PRESENT 2 0.0001
488 INTENTIONAL DOSE OMISSION 3 0.0001
489 FEELING JITTERY 2 0.0001
490 RECALLED PRODUCT ADMINISTERED 1 0.0001
491 EYE INFLAMMATION 1 0.0001
492 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
493 ASTHENIA 39 0.0001
494 ATELECTASIS 1 0.0001
495 EAR PAIN 2 0.0001
496 BLOOD PRESSURE ABNORMAL 2 0.0001
497 DRY EYE 5 0.0001
498 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
499 SPINAL FRACTURE 2 0.0001
500 BRAIN INJURY 1 0.0001
501 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
502 CELLULITIS 5 0.0001
503 CORONARY ARTERY DISEASE 3 0.0001
504 STOMATITIS 6 0.0001
505 EXTRA DOSE ADMINISTERED 4 0.0001
506 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
507 DRY THROAT 1 0.0001
508 MOTOR DYSFUNCTION 1 0.0001
509 BLOOD PRESSURE INCREASED 15 0.0001
510 THERAPY CESSATION 5 0.0001
511 LUNG NEOPLASM MALIGNANT 4 0.0001
512 RIB FRACTURE 2 0.0001
513 TEMPERATURE INTOLERANCE 1 0.0001
514 SWOLLEN TONGUE 3 0.0001
515 TENDERNESS 1 0.0001
516 PETECHIAE 1 0.0001
517 HEADACHE 60 0.0001
518 WEIGHT FLUCTUATION 1 0.0001
519 TRANSFUSION 1 0.0001
520 HEAD INJURY 3 0.0001
521 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
522 PALPITATIONS 11 0.0001
523 JOINT INJURY 2 0.0001
524 EPISTAXIS 7 0.0001
525 HIP FRACTURE 3 0.0001
526 IRRITABLE BOWEL SYNDROME 2 0.0001
527 HEREDITARY ANGIOEDEMA 1 0.0001
528 DRUG INTOLERANCE 9 0.0001
529 NIGHT SWEATS 3 0.0001
530 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
531 FAECES DISCOLOURED 2 0.0001
532 NASOPHARYNGITIS 17 0.0001
533 PRODUCT DISPENSING ERROR 2 0.0001
534 PRODUCT PRESCRIBING ISSUE 2 0.0001
535 WOUND INFECTION 1 0.0001
536 BLOOD GLUCOSE FLUCTUATION 1 0.0001
537 EYE DISORDER 3 0.0001
538 INFUSION RELATED REACTION 6 0.0001
539 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
540 TREMOR 15 0.0001
541 VIRAL INFECTION 3 0.0001
542 FUNGAL INFECTION 3 0.0001
543 TOOTH DISORDER 2 0.0001
544 HYPERTENSIVE CRISIS 1 0.0001
545 WEIGHT DECREASED 25 0.0001
546 GLOSSODYNIA 2 0.0001
547 OCULAR DISCOMFORT 1 0.0001
548 CHROMATURIA 2 0.0001
549 REBOUND EFFECT 1 0.0001
550 MITRAL VALVE INCOMPETENCE 1 0.0001
551 PRODUCT AVAILABILITY ISSUE 2 0.0001
552 SCAB 1 0.0001
553 HERPES ZOSTER 5 0.0001
554 SHOCK 2 0.0001
555 DELIRIUM 3 0.0001
556 DIZZINESS 43 0.0001
557 RENAL DISORDER 4 0.0001
558 SPINAL PAIN 1 0.0001
559 NASAL CONGESTION 5 0.0001
560 COVID-19 PNEUMONIA 1 0.0001
561 BLOOD IRON DECREASED 1 0.0001
562 THYROID CANCER 1 0.0001
563 PRESYNCOPE 2 0.0001
564 PLEURAL EFFUSION 5 0.0001
565 OEDEMA PERIPHERAL 10 0.0001
566 FEELING HOT 5 0.0001
567 ENCEPHALOPATHY 2 0.0001
568 SEPSIS 9 0.0001
569 AGEUSIA 2 0.0001
570 PNEUMONIA ASPIRATION 2 0.0001
571 PRODUCT USE ISSUE 15 0.0001
572 HYPOTENSION 16 0.0001
573 FEELING ABNORMAL 19 0.0001
574 ABDOMINAL PAIN LOWER 2 0.0001
575 INJECTION SITE IRRITATION 1 0.0001
576 DEVICE DEPLOYMENT ISSUE 1 0.0001
577 INTRAOCULAR PRESSURE INCREASED 1 0.0001
578 LOSS OF CONSCIOUSNESS 10 0.0001
579 INFLAMMATION 4 0.0001
580 SKIN ULCER 2 0.0001
581 DEAFNESS 2 0.0001
582 MUSCLE SPASMS 14 0.0001
583 GASTRITIS 2 0.0001
584 INFECTION 11 0.0001
585 BLOOD PRESSURE DECREASED 5 0.0001
586 PAIN IN EXTREMITY 22 0.0001
587 QUALITY OF LIFE DECREASED 1 0.0001
588 FATIGUE 58 0.0001
589 PSORIATIC ARTHROPATHY 3 0.0001
590 LIMB INJURY 2 0.0001
591 PNEUMONITIS 2 0.0001
592 DECREASED APPETITE 17 0.0001
593 TREATMENT NONCOMPLIANCE 4 0.0001
594 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
595 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
596 PERIPHERAL COLDNESS 1 0.0001
597 MEMORY IMPAIRMENT 10 0.0001
598 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
599 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
600 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
601 DIVERTICULITIS 2 0.0001
602 HUNGER 1 0.0001
603 BLOOD TEST ABNORMAL 1 0.0001
604 OSTEOARTHRITIS 3 0.0001
605 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
606 DIALYSIS 1 0.0001
607 HYPOACUSIS 3 0.0001
608 EYE IRRITATION 4 0.0001
609 PARAESTHESIA ORAL 1 0.0001
610 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
611 FLUSHING 7 0.0001
612 MALAISE 30 0.0001
613 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
614 THERAPY NON-RESPONDER 3 0.0001
615 HALLUCINATION 5 0.0001
616 OSTEOPENIA 1 0.0001
617 DEVICE FAILURE 1 0.0001
618 ABDOMINAL DISCOMFORT 11 0.0001
619 HIP ARTHROPLASTY 1 0.0001
620 HYPERSENSITIVITY 12 0.0001
621 TENDONITIS 1 0.0001
622 CONSTIPATION 14 0.0001
623 PRODUCT USE COMPLAINT 1 0.0001
624 CYSTITIS 2 0.0001
625 ABSCESS 1 0.0001
626 DIARRHOEA 40 0.0001
627 BLOOD POTASSIUM INCREASED 1 0.0001
628 MANIA 1 0.0001
629 INFLUENZA LIKE ILLNESS 5 0.0001
630 STAPHYLOCOCCAL INFECTION 2 0.0001
631 CARDIAC ARREST 5 0.0001
632 VENTRICULAR TACHYCARDIA 1 0.0001
633 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
634 EXPIRED PRODUCT ADMINISTERED 2 0.0001
635 FALL 20 0.0001
636 COAGULOPATHY 1 0.0001
637 SKIN DISORDER 2 0.0001
638 PERICARDITIS 1 0.0001
639 NAUSEA 47 0.0001
640 FACE OEDEMA 1 0.0001
641 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
642 FLUID RETENTION 3 0.0001
643 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
644 CIRCULATORY COLLAPSE 1 0.0001
645 HAEMATURIA 2 0.0001
646 ABDOMINAL PAIN UPPER 12 0.0001
647 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
648 DEATH 50 0.0001
649 JOINT SWELLING 7 0.0001
650 NIGHTMARE 2 0.0001
651 DEVICE USE ERROR 2 0.0001
652 NERVOUSNESS 3 0.0001
653 RASH 25 0.0001
654 DEVICE USE ISSUE 1 0.0001
655 BURNING SENSATION 4 0.0001
656 SLEEP DISORDER 4 0.0001
657 HYPERTENSION 12 0.0001
658 LYMPHOCYTE COUNT DECREASED 1 0.0001
659 DRUG ERUPTION 1 0.0001
660 GASTROENTERITIS VIRAL 1 0.0001
661 OEDEMA 3 0.0001
662 TOOTHACHE 1 0.0001
663 HYPERGLYCAEMIA 2 0.0001
664 RESTLESSNESS 2 0.0001
665 PRURITUS 21 0.0001
666 SOMNOLENCE 11 0.0001
667 AGITATION 4 0.0001
668 INJECTION SITE MASS 2 0.0001
669 URTICARIA 9 0.0001
670 HEPATIC STEATOSIS 1 0.0001
671 WEIGHT INCREASED 12 0.0001
672 SWELLING 5 0.0001
673 COLITIS 2 0.0001
674 DYSPHAGIA 5 0.0001
675 INSOMNIA 14 0.0001
676 MUSCULOSKELETAL DISORDER 1 0.0001
677 DRY SKIN 7 0.0001
678 LOWER LIMB FRACTURE 1 0.0001
679 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
680 ORAL HERPES 1 0.0001
681 CHILLS 6 0.0001
682 SURGERY 3 0.0001
683 KIDNEY INFECTION 1 0.0001
684 INJECTION SITE BRUISING 4 0.0001
685 CYTOKINE RELEASE SYNDROME 1 0.0000
686 THROMBOSIS 4 0.0000
687 PRODUCT ADMINISTRATION ERROR 1 0.0000
688 CONDITION AGGRAVATED 15 0.0000
689 FEEDING DISORDER 1 0.0000
690 TASTE DISORDER 1 0.0000
691 DISCOMFORT 3 0.0000
692 INJURY ASSOCIATED WITH DEVICE 1 0.0000
693 BODY TEMPERATURE INCREASED 1 0.0000
694 ABDOMINAL DISTENSION 5 0.0000
695 MYALGIA 8 0.0000
696 OFF LABEL USE 41 0.0000
697 LIVER FUNCTION TEST INCREASED 1 0.0000
698 AMNESIA 3 0.0000
699 DEVICE DISLOCATION 2 0.0000
700 MYOCARDIAL INFARCTION 8 0.0000
701 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
702 MELAENA 1 0.0000
703 ANGIOEDEMA 2 0.0000
704 LIVER DISORDER 2 0.0000
705 DEHYDRATION 6 0.0000
706 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
707 RASH PAPULAR 1 0.0000
708 ADVERSE DRUG REACTION 4 0.0000
709 HEART RATE IRREGULAR 1 0.0000
710 INCORRECT DOSE ADMINISTERED 10 0.0000
711 MUSCLE TWITCHING 1 0.0000
712 DISEASE RECURRENCE 2 0.0000
713 MIGRAINE 4 0.0000
714 GAIT DISTURBANCE 8 0.0000
715 OVERDOSE 9 0.0000
716 BLOOD GLUCOSE DECREASED 2 0.0000
717 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
718 INTERSTITIAL LUNG DISEASE 2 0.0000
719 MENTAL IMPAIRMENT 1 0.0000
720 NEURALGIA 1 0.0000
721 DYSPEPSIA 4 0.0000
722 DYSGEUSIA 3 0.0000
723 EXTRAPYRAMIDAL DISORDER 1 0.0000
724 HOT FLUSH 3 0.0000
725 DEPRESSION 9 0.0000
726 HAEMATEMESIS 1 0.0000
727 CARDIOVASCULAR DISORDER 1 0.0000
728 INJECTION SITE SWELLING 3 0.0000
729 HYPOPHAGIA 1 0.0000
730 PAIN 24 0.0000
731 ERECTILE DYSFUNCTION 1 0.0000
732 HYPERHIDROSIS 5 0.0000
733 UNRESPONSIVE TO STIMULI 1 0.0000
734 ARTHRALGIA 16 0.0000
735 DRUG DOSE OMISSION BY DEVICE 3 0.0000
736 JOINT STIFFNESS 1 0.0000
737 DERMATITIS ATOPIC 2 0.0000
738 PROSTATE CANCER 3 0.0000
739 RASH PRURITIC 2 0.0000
740 MOOD ALTERED 1 0.0000
741 SKIN LESION 1 0.0000
742 RESPIRATORY ARREST 1 0.0000
743 VOMITING 17 0.0000
744 PROCEDURAL PAIN 1 0.0000
745 FEELING COLD 1 0.0000
746 NECK PAIN 2 0.0000
747 DRUG INEFFECTIVE 47 0.0000
748 RHEUMATOID ARTHRITIS 4 0.0000
749 ANXIETY 10 0.0000
750 RED BLOOD CELL COUNT DECREASED 1 0.0000
751 ANGINA PECTORIS 1 0.0000
752 LETHARGY 2 0.0000
753 PRODUCT STORAGE ERROR 3 0.0000
754 BONE PAIN 2 0.0000
755 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
756 ERYTHEMA 7 0.0000
757 LABORATORY TEST ABNORMAL 1 0.0000
758 PSYCHOTIC DISORDER 1 0.0000
759 URINARY INCONTINENCE 1 0.0000
760 GASTROINTESTINAL DISORDER 3 0.0000
761 DEVICE ISSUE 3 0.0000
762 HYPOAESTHESIA 5 0.0000
763 NO ADVERSE EVENT 6 0.0000
764 LACRIMATION INCREASED 1 0.0000
765 ILL-DEFINED DISORDER 2 0.0000
766 VERTIGO 2 0.0000
767 ACUTE KIDNEY INJURY 5 0.0000
768 INJECTION SITE PAIN 10 0.0000
769 INJECTION SITE RASH 1 0.0000
770 ADVERSE EVENT 3 0.0000
771 INJECTION SITE ERYTHEMA 4 0.0000
772 PARAESTHESIA 5 0.0000
773 NEUROPATHY PERIPHERAL 3 0.0000
774 ANAEMIA 6 0.0000
775 MOOD SWINGS 1 0.0000
776 METABOLIC ACIDOSIS 1 0.0000
777 CONFUSIONAL STATE 5 0.0000
778 LACTIC ACIDOSIS 1 0.0000
779 PRODUCT DOSE OMISSION 2 0.0000
780 OSTEONECROSIS 1 0.0000
781 DEVICE DIFFICULT TO USE 2 0.0000
782 VISUAL ACUITY REDUCED 1 0.0000
783 ABDOMINAL PAIN 7 0.0000
784 NEOPLASM MALIGNANT 2 0.0000
785 TYPE 2 DIABETES MELLITUS 1 0.0000
786 HAEMORRHAGE 3 0.0000
787 HYPERKALAEMIA 1 0.0000
788 INJURY 2 0.0000
789 PLATELET COUNT DECREASED 3 0.0000
790 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
791 MOBILITY DECREASED 2 0.0000
792 CRYING 1 0.0000
793 HEPATIC FUNCTION ABNORMAL 1 0.0000
794 UNEVALUABLE EVENT 2 0.0000
795 MUSCULAR WEAKNESS 3 0.0000
796 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
797 PLASMA CELL MYELOMA 1 0.0000
798 ARTHRITIS 2 0.0000
799 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
800 DRUG INTERACTION 4 0.0000
801 CARDIAC FAILURE 2 0.0000
802 DEVICE BREAKAGE 1 0.0000
803 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
804 ROAD TRAFFIC ACCIDENT 1 0.0000
805 RECTAL HAEMORRHAGE 1 0.0000
806 BALANCE DISORDER 2 0.0000
807 DEVICE LEAKAGE 1 0.0000
808 MUSCULOSKELETAL STIFFNESS 2 0.0000
809 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
810 SKIN IRRITATION 1 0.0000
811 TINNITUS 1 0.0000
812 SKIN DISCOLOURATION 1 0.0000
813 HYPOKALAEMIA 1 0.0000
814 COGNITIVE DISORDER 1 0.0000
815 BLOOD GLUCOSE INCREASED 4 0.0000
816 ARRHYTHMIA 1 0.0000
817 MULTIPLE SCLEROSIS 1 0.0000
818 PYREXIA 7 0.0000
819 SYNCOPE 2 0.0000
820 AGGRESSION 1 0.0000
821 ECZEMA 1 0.0000
822 DEPRESSED MOOD 1 0.0000
823 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
824 ANAPHYLACTIC REACTION 1 0.0000
825 TOXICITY TO VARIOUS AGENTS 3 0.0000
826 CEREBROVASCULAR ACCIDENT 3 0.0000
827 FLATULENCE 1 0.0000
828 PRODUCT SUBSTITUTION ISSUE 1 0.0000
829 DISEASE PROGRESSION 2 0.0000
830 IRRITABILITY 1 0.0000
831 DEEP VEIN THROMBOSIS 1 0.0000
832 ALOPECIA 3 0.0000
833 INJECTION SITE PRURITUS 1 0.0000
834 PRODUCT QUALITY ISSUE 2 0.0000
835 SKIN BURNING SENSATION 1 0.0000
836 DIABETES MELLITUS 1 0.0000
837 TREATMENT FAILURE 1 0.0000
838 DRUG ABUSE 1 0.0000
839 RENAL IMPAIRMENT 1 0.0000
840 SKIN EXFOLIATION 1 0.0000
841 INTENTIONAL PRODUCT MISUSE 1 0.0000
842 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
843 BREAST CANCER 1 0.0000
844 PULMONARY EMBOLISM 1 0.0000
845 HAEMOGLOBIN DECREASED 1 0.0000
846 RENAL FAILURE 1 0.0000
847 NEUTROPENIA 1 0.0000